dr. bekaii-saab on the redos study in metastatic colorectal cancer
Published 6 years ago • 124 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
0:57
dr. bekaii-saab on the importance of the redos study in mcrc
-
1:39
dr. bekaii-saab on microsatellite instability in colorectal cancer
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
5:15
multidisciplinary care in metastatic colorectal cancer
-
49:14
inflammatory bowel disease
-
5:16
rachael wall, 26 year old stage iv colorectal cancer survivor, says yes to hope!
-
14:07
strategies in metastatic colorectal cancer
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
1:07
what are the treatment options for colorectal cancer? - dr. tanios bekaii-saab
-
5:54
initial systemic therapy for metastatic colorectal cancer
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:49
dr. bekaii-saab on immunotherapy in colorectal cancer
-
5:35
emerging therapy in metastatic colorectal cancer
-
6:59
optimizing frontline chemotherapy in metastatic colorectal cancer
-
5:07
neoadjuvant and adjuvant therapy in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
9:00
first- and later-line use of panitumumab in metastatic colorectal cancer
-
8:41
calgb 80405 trial results in metastatic colorectal cancer
-
9:05
determining optimal treatments in metastatic colorectal cancer